Search
10 Feb PENUT Trial Seeks to Improve Well Being of Premature Babies
The PENUT (Preterm Epo Neuroprotection) trial is a new study being led by University of Washington researchers who are assessing whether erythropoietin (Epo) can provide neurological protection for infants who are born extremely prematurely. This study is seeking a treatment for the approximately 50,000 infants a year in the United States who are born at less than 28 weeks of...
10 Feb REDCap Supports Resident’s Unconventional Research Pursuits
Dr. Aaron Kusano, a resident in the University of Washington Department of Radiation Oncology, has research interests that he admits fall a bit outside the conventional realm of radiation oncology. He has examined the burnout amongst academic chairs of radiation oncology departments in the past. He also took a look at the bereavement practices of cancer and palliative care physicians...
14 Jan Chinese Research Delegation Visits ITHS
The Institute of Translational Health Sciences (ITHS) hosted 14 researchers from five different Chinese hospitals on Tuesday, January 14, 2014. The delegation, which was organized and led by Dr. Tim Shi of GlobalMD, was interested in learning more about translational research, the ITHS Clinical Research Center, other ITHS clinical resources, stakeholder engagement, and the ITHS strategic planning process and subsequent...
05 Sep On the path to commercializing a trauma care device
If a trauma patient has uncontrolled bleeding, the therapeutic priority is to stop the bleeding as quickly as possible. However, a patient may have hard-to-diagnose, life-threatening condition called trauma-induced coagulopathy (TIC) that can increase blood loss. A team led by Nathan Sniadecki in the UW Department of Mechanical Engineering and Nathan White in the UW Division of Emergency Medicine is...
30 May Technology Pilot Leads to $1.9 million NSF Award
When you meet Tueng Shen, who is both a medical doctor seeing patients and a researcher and engineer, she makes you comfortable right away. She uses her own story of straddling cultures to illustrate a special strength of the translational sciences world, where she feels her own straddling of engineering and clinical practice is celebrated and encouraged by the Institute...
12 Jul Gene and Cell Therapy Lab now open for researchers
The Institute of Translational Health Sciences has reopened its Gene and Cell Therapy Lab. As a biologic manufacturing facility designed to support Phase I/II clinical trials, the lab recently redesigned its operations to address the unique requirements for novel gene and cell therapy products. Located within the UW Medical Center, the 2200 sq.ft clean room facility is ISO class 7,...
19 Jun ITHS Member receives NIH Funding
In the world of drug development, researchers may experience many false starts and tests before a compound successfully makes it through clinical trials and enters the market. In fact, approximately 1 in 12 treatments ever make it to patients. What happens to promising molecular compounds that have undergone extensive pre-clinical and safety testing but don’t quite reach the market? The...
03 Nov We’ve made it easy to cite ITHS
If you’ve been the recipient of ITHS resources, please mention us in your publication, press release, or presentation. Just copy and paste our pre-written text into your document. We’ve included the basic guidelines below. Thank you for your cooperation in acknowledging our support of your work. Example Citations “This publication [or project] was supported by the National Center For Advancing...